[Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
D001238:Asphyxia Neonatorum / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D010102:Oxygen Inhalation Therapy; D010530:Peritoneal Dialysis; D011650:Pulmonary Alveoli; D001261:Pulmonary Atelectasis / Q000150:complications; D011663:Pulmonary Surfactants; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000209:etiology / Q000628:therapy
D011663:Pulmonary Surfactants
Membransyndrom (Atemnotsyndrom) der Frühgeborenen. Pathogenese und Therapie unter besonderer Berücksichtigung der alveolären oberflächenaktiven Substanz.